- We will send in 10–14 business days.
/images/books/4585209/9780896036291.jpg)
- Publisher: Humana
- ISBN-10: 0896036294
- ISBN-13: 9780896036291
- Format: 17.8 x 25.4 x 1.8 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Farnesyltransferase Inhibitors in Cancer Therapy (e-book) (used book) | bookbook.eu
Reviews
Description
Cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farensyltransferase inhibitors (FTIs); geranylgeranyltransferase inhibitors (GGTIs) are also discussed as potential anticancer drugs. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 19d.17:12:34
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Humana
- ISBN-10: 0896036294
- ISBN-13: 9780896036291
- Format: 17.8 x 25.4 x 1.8 cm, hardcover
- Language: English English
Cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farensyltransferase inhibitors (FTIs); geranylgeranyltransferase inhibitors (GGTIs) are also discussed as potential anticancer drugs. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.
Reviews